Related references
Note: Only part of the references are listed.mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
mTOR is required for pulmonary arterial vascular smooth muscle cell proliferation under chronic hypoxia
Vera P. Krymskaya et al.
FASEB JOURNAL (2011)
Dramatic Improvement in Pulmonary Hypertension With Rapamycin
Jeffrey D. Wessler et al.
CHEST (2010)
Effects of HIV Protease Inhibitors on Progression of Monocrotaline- and Hypoxia-Induced Pulmonary Hypertension in Rats
Guillaume Gary-Bobo et al.
CIRCULATION (2010)
Mammalian Target of Rapamycin (mTOR): Conducting the Cellular Signaling Symphony
Kathryn G. Foster et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Endothelial-derived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents
Mohamed Izikki et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Cellular and Molecular Basis of Pulmonary Arterial Hypertension
Nicholas W. Morrell et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
The Pharmacology of mTOR Inhibition
David A. Guertin et al.
SCIENCE SIGNALING (2009)
Statin therapy, alone or with rapamycin, does not reverse monocrotaline pulmonary arterial hypertension: the rapamcyin-atorvastatin-simvastatin study
M. Sean McMurtry et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
Akt inhibitor A-443654 induces rapid Akt Ser-473 phosphorylation independent of mTORC1 inhibition
E. K-H Han et al.
ONCOGENE (2007)
Rapamycin attenuates hypoxia-induced pulmonary vascular remodeling and right ventricular hypertrophy in mice
Renate Paddenberg et al.
RESPIRATORY RESEARCH (2007)
Platelet-derived growth factor BB induces nuclear export and proteasomal degradation of CREB via phosphatidylinositol. 3-kinase/Akt signaling in pulmonary artery smooth muscle cells
Chrystelle V. Garat et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB
DD Sarbassov et al.
MOLECULAR CELL (2006)
TOR signaling in growth and metabolism
S Wullschleger et al.
CELL (2006)
Serotonin-induced growth of pulmonary artery smooth muscle requires activation of phosphatidylinositol 3-kinase/serine-threonine protein kinase B/mammalian target of rapamycin/p70 ribosomal S6 kinase 1
YL Liu et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2006)
TOR signaling in growth and metabolism
Stephan Wullschleger et al.
CELL (2006)
Heme oxygenase-1 mediates the protective effects of rapamycin in monocrotaline-induced pulmonary hypertension
HL Zhou et al.
LABORATORY INVESTIGATION (2006)
Reversal of experimental pulmonary hypertension by PDGF inhibition
RT Schermuly et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
DD Sarbassov et al.
SCIENCE (2005)
The phosphatidylinositol 3-kinase-AKT pathway in human cancer
I Vivanco et al.
NATURE REVIEWS CANCER (2002)
Hypoxia enhances vascular cell proliferation and angiogenesis in vitro via rapamycin (mTOR) -dependent signaling
R Humar et al.
FASEB JOURNAL (2002)
40-O-(2-hydroxyethyl)-rapamycin attenuates pulmonary arterial hypertension and neointimal formation in rats
T Nishimura et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Share Paper
